ID   CLK3_HUMAN              Reviewed;         638 AA.
AC   P49761; D3DW59; Q53Y48; Q9BRS3; Q9BUJ7;
DT   01-OCT-1996, integrated into UniProtKB/Swiss-Prot.
DT   12-JUN-2007, sequence version 3.
DT   12-OCT-2022, entry version 217.
DE   RecName: Full=Dual specificity protein kinase CLK3;
DE            EC=2.7.12.1;
DE   AltName: Full=CDC-like kinase 3;
GN   Name=CLK3;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS 1 AND 2).
RX   PubMed=7990150; DOI=10.1006/jmbi.1994.1763;
RA   Hanes J.J., der Kammer H., Klaudiny J.J., Scheit K.H.;
RT   "Characterization by cDNA cloning of two new human protein kinases.
RT   Evidence by sequence comparison of a new family of mammalian protein
RT   kinases.";
RL   J. Mol. Biol. 244:665-672(1994).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RA   Kalnine N., Chen X., Rolfs A., Halleck A., Hines L., Eisenstein S.,
RA   Koundinya M., Raphael J., Moreira D., Kelley T., LaBaer J., Lin Y.,
RA   Phelan M., Farmer A.;
RT   "Cloning of human full-length CDSs in BD Creator(TM) system donor vector.";
RL   Submitted (MAY-2003) to the EMBL/GenBank/DDBJ databases.
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16572171; DOI=10.1038/nature04601;
RA   Zody M.C., Garber M., Sharpe T., Young S.K., Rowen L., O'Neill K.,
RA   Whittaker C.A., Kamal M., Chang J.L., Cuomo C.A., Dewar K.,
RA   FitzGerald M.G., Kodira C.D., Madan A., Qin S., Yang X., Abbasi N.,
RA   Abouelleil A., Arachchi H.M., Baradarani L., Birditt B., Bloom S.,
RA   Bloom T., Borowsky M.L., Burke J., Butler J., Cook A., DeArellano K.,
RA   DeCaprio D., Dorris L. III, Dors M., Eichler E.E., Engels R., Fahey J.,
RA   Fleetwood P., Friedman C., Gearin G., Hall J.L., Hensley G., Johnson E.,
RA   Jones C., Kamat A., Kaur A., Locke D.P., Madan A., Munson G., Jaffe D.B.,
RA   Lui A., Macdonald P., Mauceli E., Naylor J.W., Nesbitt R., Nicol R.,
RA   O'Leary S.B., Ratcliffe A., Rounsley S., She X., Sneddon K.M.B.,
RA   Stewart S., Sougnez C., Stone S.M., Topham K., Vincent D., Wang S.,
RA   Zimmer A.R., Birren B.W., Hood L., Lander E.S., Nusbaum C.;
RT   "Analysis of the DNA sequence and duplication history of human chromosome
RT   15.";
RL   Nature 440:671-675(2006).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L., Mobarry C.M.,
RA   Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J.,
RA   Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S.,
RA   Turner R., Yooseph S., Lu F., Nusskern D.R., Shue B.C., Zheng X.H.,
RA   Zhong F., Delcher A.L., Huson D.H., Kravitz S.A., Mouchard L., Reinert K.,
RA   Remington K.A., Clark A.G., Waterman M.S., Eichler E.E., Adams M.D.,
RA   Hunkapiller M.W., Myers E.W., Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 3), AND NUCLEOTIDE SEQUENCE
RP   [LARGE SCALE MRNA] OF 137-638 (ISOFORM 4).
RC   TISSUE=Cervix, and Placenta;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [6]
RP   FUNCTION, SUBCELLULAR LOCATION, AND PHOSPHORYLATION.
RX   PubMed=9637771; DOI=10.1006/excr.1998.4083;
RA   Duncan P.I., Stojdl D.F., Marius R.M., Scheit K.H., Bell J.C.;
RT   "The Clk2 and Clk3 dual-specificity protein kinases regulate the
RT   intranuclear distribution of SR proteins and influence pre-mRNA splicing.";
RL   Exp. Cell Res. 241:300-308(1998).
RN   [7]
RP   SPLICE ISOFORM(S) THAT ARE POTENTIAL NMD TARGET(S).
RX   PubMed=14759258; DOI=10.1186/gb-2004-5-2-r8;
RA   Hillman R.T., Green R.E., Brenner S.E.;
RT   "An unappreciated role for RNA surveillance.";
RL   Genome Biol. 5:R8.1-R8.16(2004).
RN   [8]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=17081983; DOI=10.1016/j.cell.2006.09.026;
RA   Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P., Mann M.;
RT   "Global, in vivo, and site-specific phosphorylation dynamics in signaling
RT   networks.";
RL   Cell 127:635-648(2006).
RN   [9]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-283, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18691976; DOI=10.1016/j.molcel.2008.07.007;
RA   Daub H., Olsen J.V., Bairlein M., Gnad F., Oppermann F.S., Korner R.,
RA   Greff Z., Keri G., Stemmann O., Mann M.;
RT   "Kinase-selective enrichment enables quantitative phosphoproteomics of the
RT   kinome across the cell cycle.";
RL   Mol. Cell 31:438-448(2008).
RN   [10]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-155; SER-157; SER-224 AND
RP   SER-226, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [11]
RP   FUNCTION, ALTERNATIVE SPLICING, AND TISSUE SPECIFICITY.
RX   PubMed=19168442; DOI=10.1161/circresaha.108.183905;
RA   Eisenreich A., Bogdanov V.Y., Zakrzewicz A., Pries A., Antoniak S.,
RA   Poller W., Schultheiss H.P., Rauch U.;
RT   "Cdc2-like kinases and DNA topoisomerase I regulate alternative splicing of
RT   tissue factor in human endothelial cells.";
RL   Circ. Res. 104:589-599(2009).
RN   [12]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-157, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Leukemic T-cell;
RX   PubMed=19690332; DOI=10.1126/scisignal.2000007;
RA   Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,
RA   Rodionov V., Han D.K.;
RT   "Quantitative phosphoproteomic analysis of T cell receptor signaling
RT   reveals system-wide modulation of protein-protein interactions.";
RL   Sci. Signal. 2:RA46-RA46(2009).
RN   [13]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-215; SER-224 AND SER-226, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=20068231; DOI=10.1126/scisignal.2000475;
RA   Olsen J.V., Vermeulen M., Santamaria A., Kumar C., Miller M.L.,
RA   Jensen L.J., Gnad F., Cox J., Jensen T.S., Nigg E.A., Brunak S., Mann M.;
RT   "Quantitative phosphoproteomics reveals widespread full phosphorylation
RT   site occupancy during mitosis.";
RL   Sci. Signal. 3:RA3-RA3(2010).
RN   [14]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-157; SER-197; SER-199 AND
RP   SER-283, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma, and Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [15]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-157, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D., Wang L.,
RA   Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human liver
RT   phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [16]
RP   X-RAY CRYSTALLOGRAPHY (1.53 ANGSTROMS) OF 284-638.
RA   Papagrigoriou E., Rellos P., Das S., Ugochukwu E., Turnbull A.,
RA   von Delft F., Bunkoczi G., Sobott F., Bullock A., Fedorov O., Gileadi C.,
RA   Savitsky P., Edwards A., Aerrowsmith C., Weigel J., Sundstrom M., Knapp S.;
RT   "Crystal structure of CLK3.";
RL   Submitted (NOV-2005) to the PDB data bank.
RN   [17]
RP   X-RAY CRYSTALLOGRAPHY (2.35 ANGSTROMS) OF 275-627.
RG   Structural genomics consortium (SGC);
RT   "Crystal structure of the phosphorylated clk3.";
RL   Submitted (APR-2007) to the PDB data bank.
RN   [18]
RP   X-RAY CRYSTALLOGRAPHY (2.09 ANGSTROMS) OF 275-632 IN COMPLEX WITH
RP   LEUCETTINE L41.
RX   PubMed=21615147; DOI=10.1021/jm200274d;
RA   Debdab M., Carreaux F., Renault S., Soundararajan M., Fedorov O.,
RA   Filippakopoulos P., Lozach O., Babault L., Tahtouh T., Baratte B.,
RA   Ogawa Y., Hagiwara M., Eisenreich A., Rauch U., Knapp S., Meijer L.,
RA   Bazureau J.P.;
RT   "Leucettines, a class of potent inhibitors of cdc2-like kinases and dual
RT   specificity, tyrosine phosphorylation regulated kinases derived from the
RT   marine sponge leucettamine B: modulation of alternative pre-RNA splicing.";
RL   J. Med. Chem. 54:4172-4186(2011).
RN   [19]
RP   VARIANTS [LARGE SCALE ANALYSIS] CYS-486; ARG-607 AND TRP-628.
RX   PubMed=17344846; DOI=10.1038/nature05610;
RA   Greenman C., Stephens P., Smith R., Dalgliesh G.L., Hunter C., Bignell G.,
RA   Davies H., Teague J., Butler A., Stevens C., Edkins S., O'Meara S.,
RA   Vastrik I., Schmidt E.E., Avis T., Barthorpe S., Bhamra G., Buck G.,
RA   Choudhury B., Clements J., Cole J., Dicks E., Forbes S., Gray K.,
RA   Halliday K., Harrison R., Hills K., Hinton J., Jenkinson A., Jones D.,
RA   Menzies A., Mironenko T., Perry J., Raine K., Richardson D., Shepherd R.,
RA   Small A., Tofts C., Varian J., Webb T., West S., Widaa S., Yates A.,
RA   Cahill D.P., Louis D.N., Goldstraw P., Nicholson A.G., Brasseur F.,
RA   Looijenga L., Weber B.L., Chiew Y.-E., DeFazio A., Greaves M.F.,
RA   Green A.R., Campbell P., Birney E., Easton D.F., Chenevix-Trench G.,
RA   Tan M.-H., Khoo S.K., Teh B.T., Yuen S.T., Leung S.Y., Wooster R.,
RA   Futreal P.A., Stratton M.R.;
RT   "Patterns of somatic mutation in human cancer genomes.";
RL   Nature 446:153-158(2007).
CC   -!- FUNCTION: Dual specificity kinase acting on both serine/threonine and
CC       tyrosine-containing substrates. Phosphorylates serine- and arginine-
CC       rich (SR) proteins of the spliceosomal complex. May be a constituent of
CC       a network of regulatory mechanisms that enable SR proteins to control
CC       RNA splicing and can cause redistribution of SR proteins from speckles
CC       to a diffuse nucleoplasmic distribution. Phosphorylates SRSF1 and
CC       SRSF3. Regulates the alternative splicing of tissue factor (F3) pre-
CC       mRNA in endothelial cells. {ECO:0000269|PubMed:19168442,
CC       ECO:0000269|PubMed:9637771}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=ATP + L-seryl-[protein] = ADP + H(+) + O-phospho-L-seryl-
CC         [protein]; Xref=Rhea:RHEA:17989, Rhea:RHEA-COMP:9863, Rhea:RHEA-
CC         COMP:11604, ChEBI:CHEBI:15378, ChEBI:CHEBI:29999, ChEBI:CHEBI:30616,
CC         ChEBI:CHEBI:83421, ChEBI:CHEBI:456216; EC=2.7.12.1;
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=ATP + L-threonyl-[protein] = ADP + H(+) + O-phospho-L-
CC         threonyl-[protein]; Xref=Rhea:RHEA:46608, Rhea:RHEA-COMP:11060,
CC         Rhea:RHEA-COMP:11605, ChEBI:CHEBI:15378, ChEBI:CHEBI:30013,
CC         ChEBI:CHEBI:30616, ChEBI:CHEBI:61977, ChEBI:CHEBI:456216;
CC         EC=2.7.12.1;
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=ATP + L-tyrosyl-[protein] = ADP + H(+) + O-phospho-L-tyrosyl-
CC         [protein]; Xref=Rhea:RHEA:10596, Rhea:RHEA-COMP:10136, Rhea:RHEA-
CC         COMP:10137, ChEBI:CHEBI:15378, ChEBI:CHEBI:30616, ChEBI:CHEBI:46858,
CC         ChEBI:CHEBI:82620, ChEBI:CHEBI:456216; EC=2.7.12.1;
CC   -!- ACTIVITY REGULATION: Leucettine L41 inhibits its kinase activity and
CC       affects the regulation of alternative splicing mediated by
CC       phosphorylation of SR proteins.
CC   -!- INTERACTION:
CC       P49761; Q8IWX8: CHERP; NbExp=3; IntAct=EBI-745579, EBI-2555370;
CC       P49761; Q8N2M8: CLASRP; NbExp=4; IntAct=EBI-745579, EBI-751069;
CC       P49761; P49760: CLK2; NbExp=13; IntAct=EBI-745579, EBI-750020;
CC       P49761; P49761: CLK3; NbExp=6; IntAct=EBI-745579, EBI-745579;
CC       P49761; Q96D03: DDIT4L; NbExp=3; IntAct=EBI-745579, EBI-742054;
CC       P49761; P17509: HOXB6; NbExp=6; IntAct=EBI-745579, EBI-741308;
CC       P49761; P09629: HOXB7; NbExp=6; IntAct=EBI-745579, EBI-1248457;
CC       P49761; P09017: HOXC4; NbExp=3; IntAct=EBI-745579, EBI-3923226;
CC       P49761; P08238: HSP90AB1; NbExp=2; IntAct=EBI-745579, EBI-352572;
CC       P49761; Q0VD86: INCA1; NbExp=3; IntAct=EBI-745579, EBI-6509505;
CC       P49761; Q8TBB1: LNX1; NbExp=3; IntAct=EBI-745579, EBI-739832;
CC       P49761; Q5M9Q1: NKAPL; NbExp=3; IntAct=EBI-745579, EBI-11423380;
CC       P49761; Q9UBU9: NXF1; NbExp=3; IntAct=EBI-745579, EBI-398874;
CC       P49761; P29728: OAS2; NbExp=4; IntAct=EBI-745579, EBI-10211452;
CC       P49761; P29728-2: OAS2; NbExp=5; IntAct=EBI-745579, EBI-12270678;
CC       P49761; P38159: RBMX; NbExp=3; IntAct=EBI-745579, EBI-743526;
CC       P49761; P0DJD3: RBMY1A1; NbExp=3; IntAct=EBI-745579, EBI-8638511;
CC       P49761; Q15415: RBMY1J; NbExp=3; IntAct=EBI-745579, EBI-8642021;
CC       P49761; O76064: RNF8; NbExp=3; IntAct=EBI-745579, EBI-373337;
CC       P49761; Q15287: RNPS1; NbExp=4; IntAct=EBI-745579, EBI-395959;
CC       P49761; Q9BUV0: RSRP1; NbExp=11; IntAct=EBI-745579, EBI-745604;
CC       P49761; P10523: SAG; NbExp=3; IntAct=EBI-745579, EBI-1642180;
CC       P49761; O00560: SDCBP; NbExp=6; IntAct=EBI-745579, EBI-727004;
CC       P49761; O14492-2: SH2B2; NbExp=3; IntAct=EBI-745579, EBI-19952306;
CC       P49761; Q8TAD8: SNIP1; NbExp=3; IntAct=EBI-745579, EBI-749336;
CC       P49761; Q16560-2: SNRNP35; NbExp=3; IntAct=EBI-745579, EBI-12938570;
CC       P49761; P78362: SRPK2; NbExp=5; IntAct=EBI-745579, EBI-593303;
CC       P49761; O75494: SRSF10; NbExp=3; IntAct=EBI-745579, EBI-353655;
CC       P49761; P84103: SRSF3; NbExp=3; IntAct=EBI-745579, EBI-372557;
CC       P49761; Q9BRL6-2: SRSF8; NbExp=3; IntAct=EBI-745579, EBI-10976394;
CC       P49761; O43463: SUV39H1; NbExp=2; IntAct=EBI-745579, EBI-349968;
CC       P49761; Q9BSI4: TINF2; NbExp=2; IntAct=EBI-745579, EBI-717399;
CC       P49761; P62995: TRA2B; NbExp=8; IntAct=EBI-745579, EBI-725485;
CC       P49761; O14978: ZNF263; NbExp=3; IntAct=EBI-745579, EBI-744493;
CC       P49761; Q8WTR7: ZNF473; NbExp=3; IntAct=EBI-745579, EBI-751409;
CC       P49761; Q9ULD5: ZNF777; NbExp=3; IntAct=EBI-745579, EBI-11975599;
CC       P49761; Q9Y2P0: ZNF835; NbExp=5; IntAct=EBI-745579, EBI-5667516;
CC   -!- SUBCELLULAR LOCATION: [Isoform 1]: Nucleus. Cytoplasm {ECO:0000250}.
CC       Cytoplasmic vesicle, secretory vesicle, acrosome {ECO:0000250}.
CC   -!- SUBCELLULAR LOCATION: [Isoform 2]: Nucleus speckle. Note=Co-localizes
CC       with serine- and arginine-rich (SR) proteins in the nuclear speckles.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=4;
CC       Name=4;
CC         IsoId=P49761-4; Sequence=Displayed;
CC       Name=1; Synonyms=Long;
CC         IsoId=P49761-1; Sequence=VSP_026138;
CC       Name=2; Synonyms=Short;
CC         IsoId=P49761-2; Sequence=VSP_026138, VSP_004858, VSP_004859;
CC       Name=3;
CC         IsoId=P49761-3; Sequence=VSP_026138, VSP_004860;
CC   -!- TISSUE SPECIFICITY: Endothelial cells. {ECO:0000269|PubMed:19168442}.
CC   -!- PTM: Autophosphorylates on all three types of residues. {ECO:0000250}.
CC   -!- MISCELLANEOUS: [Isoform 2]: Lacks the kinase domain. May be produced at
CC       very low levels due to a premature stop codon in the mRNA, leading to
CC       nonsense-mediated mRNA decay. {ECO:0000305}.
CC   -!- SIMILARITY: Belongs to the protein kinase superfamily. CMGC Ser/Thr
CC       protein kinase family. Lammer subfamily. {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAH02555.1; Type=Erroneous initiation; Note=Truncated N-terminus.; Evidence={ECO:0000305};
CC       Sequence=AAH19881.1; Type=Erroneous initiation; Note=Truncated N-terminus.; Evidence={ECO:0000305};
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; L29220; AAA61483.1; -; mRNA.
DR   EMBL; L29217; AAA61484.1; -; mRNA.
DR   EMBL; BT006993; AAP35639.1; -; mRNA.
DR   EMBL; AC100835; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471136; EAW99321.1; -; Genomic_DNA.
DR   EMBL; CH471136; EAW99322.1; -; Genomic_DNA.
DR   EMBL; BC002555; AAH02555.1; ALT_INIT; mRNA.
DR   EMBL; BC006103; AAH06103.1; -; mRNA.
DR   EMBL; BC019881; AAH19881.1; ALT_INIT; mRNA.
DR   CCDS; CCDS10265.1; -. [P49761-1]
DR   CCDS; CCDS45304.1; -. [P49761-1]
DR   PIR; S53639; S53639.
DR   PIR; S53640; S53640.
DR   RefSeq; NP_001123500.1; NM_001130028.1. [P49761-1]
DR   RefSeq; NP_003983.2; NM_003992.4. [P49761-1]
DR   RefSeq; XP_016877398.1; XM_017021909.1.
DR   RefSeq; XP_016877399.1; XM_017021910.1.
DR   PDB; 2EU9; X-ray; 1.53 A; A=284-638.
DR   PDB; 2EXE; X-ray; 2.35 A; A=275-631.
DR   PDB; 2WU6; X-ray; 1.92 A; A=275-632.
DR   PDB; 2WU7; X-ray; 2.25 A; A=275-632.
DR   PDB; 3RAW; X-ray; 2.09 A; A/B=275-632.
DR   PDB; 6FT7; X-ray; 2.02 A; A/B=275-632.
DR   PDB; 6FYP; X-ray; 2.29 A; A=275-632.
DR   PDB; 6FYR; X-ray; 1.42 A; A=275-632.
DR   PDB; 6KHF; X-ray; 2.60 A; A=149-638.
DR   PDB; 6RCT; X-ray; 2.32 A; A/B=275-632.
DR   PDB; 6YTW; X-ray; 2.00 A; A/B=275-632.
DR   PDB; 6YTY; X-ray; 1.76 A; A=275-632.
DR   PDB; 6YU1; X-ray; 1.90 A; a/c=275-632.
DR   PDB; 6Z2V; X-ray; 2.60 A; A=275-632.
DR   PDB; 6Z51; X-ray; 1.92 A; A=275-632.
DR   PDB; 6Z52; X-ray; 2.12 A; A/B=275-632.
DR   PDB; 6Z53; X-ray; 1.65 A; A=275-632.
DR   PDB; 6Z54; X-ray; 1.73 A; A=275-632.
DR   PDB; 6Z55; X-ray; 1.70 A; A/B=275-632.
DR   PDBsum; 2EU9; -.
DR   PDBsum; 2EXE; -.
DR   PDBsum; 2WU6; -.
DR   PDBsum; 2WU7; -.
DR   PDBsum; 3RAW; -.
DR   PDBsum; 6FT7; -.
DR   PDBsum; 6FYP; -.
DR   PDBsum; 6FYR; -.
DR   PDBsum; 6KHF; -.
DR   PDBsum; 6RCT; -.
DR   PDBsum; 6YTW; -.
DR   PDBsum; 6YTY; -.
DR   PDBsum; 6YU1; -.
DR   PDBsum; 6Z2V; -.
DR   PDBsum; 6Z51; -.
DR   PDBsum; 6Z52; -.
DR   PDBsum; 6Z53; -.
DR   PDBsum; 6Z54; -.
DR   PDBsum; 6Z55; -.
DR   AlphaFoldDB; P49761; -.
DR   SMR; P49761; -.
DR   BioGRID; 107609; 193.
DR   IntAct; P49761; 139.
DR   MINT; P49761; -.
DR   STRING; 9606.ENSP00000378505; -.
DR   BindingDB; P49761; -.
DR   ChEMBL; CHEMBL4226; -.
DR   DrugBank; DB08691; ethyl 3-[(E)-2-amino-1-cyanoethenyl]-6,7-dichloro-1-methyl-1H-indole-2-carboxylate.
DR   DrugBank; DB12010; Fostamatinib.
DR   DrugBank; DB07664; K-00546.
DR   DrugCentral; P49761; -.
DR   GuidetoPHARMACOLOGY; 1992; -.
DR   iPTMnet; P49761; -.
DR   PhosphoSitePlus; P49761; -.
DR   BioMuta; CLK3; -.
DR   DMDM; 148887358; -.
DR   EPD; P49761; -.
DR   jPOST; P49761; -.
DR   MassIVE; P49761; -.
DR   MaxQB; P49761; -.
DR   PaxDb; P49761; -.
DR   PeptideAtlas; P49761; -.
DR   PRIDE; P49761; -.
DR   ProteomicsDB; 56096; -. [P49761-4]
DR   ProteomicsDB; 56097; -. [P49761-1]
DR   ProteomicsDB; 56098; -. [P49761-2]
DR   ProteomicsDB; 56099; -. [P49761-3]
DR   Antibodypedia; 26974; 160 antibodies from 26 providers.
DR   DNASU; 1198; -.
DR   Ensembl; ENST00000345005.8; ENSP00000344112.4; ENSG00000179335.20. [P49761-1]
DR   Ensembl; ENST00000395066.9; ENSP00000378505.4; ENSG00000179335.20. [P49761-1]
DR   Ensembl; ENST00000483723.5; ENSP00000431825.1; ENSG00000179335.20. [P49761-2]
DR   GeneID; 1198; -.
DR   KEGG; hsa:1198; -.
DR   MANE-Select; ENST00000395066.9; ENSP00000378505.4; NM_001130028.2; NP_001123500.2. [P49761-1]
DR   UCSC; uc002ayg.4; human. [P49761-4]
DR   CTD; 1198; -.
DR   DisGeNET; 1198; -.
DR   GeneCards; CLK3; -.
DR   HGNC; HGNC:2071; CLK3.
DR   HPA; ENSG00000179335; Low tissue specificity.
DR   MIM; 602990; gene.
DR   neXtProt; NX_P49761; -.
DR   OpenTargets; ENSG00000179335; -.
DR   PharmGKB; PA26597; -.
DR   VEuPathDB; HostDB:ENSG00000179335; -.
DR   eggNOG; KOG0671; Eukaryota.
DR   GeneTree; ENSGT00940000160359; -.
DR   HOGENOM; CLU_000288_5_16_1; -.
DR   InParanoid; P49761; -.
DR   PhylomeDB; P49761; -.
DR   TreeFam; TF101041; -.
DR   BRENDA; 2.7.12.1; 2681.
DR   PathwayCommons; P49761; -.
DR   SignaLink; P49761; -.
DR   SIGNOR; P49761; -.
DR   BioGRID-ORCS; 1198; 28 hits in 1110 CRISPR screens.
DR   ChiTaRS; CLK3; human.
DR   EvolutionaryTrace; P49761; -.
DR   GeneWiki; CLK3_(gene); -.
DR   GenomeRNAi; 1198; -.
DR   Pharos; P49761; Tchem.
DR   PRO; PR:P49761; -.
DR   Proteomes; UP000005640; Chromosome 15.
DR   RNAct; P49761; protein.
DR   Bgee; ENSG00000179335; Expressed in lower esophagus mucosa and 191 other tissues.
DR   ExpressionAtlas; P49761; baseline and differential.
DR   Genevisible; P49761; HS.
DR   GO; GO:0001669; C:acrosomal vesicle; IEA:UniProtKB-SubCell.
DR   GO; GO:0045111; C:intermediate filament cytoskeleton; IDA:HPA.
DR   GO; GO:0016020; C:membrane; HDA:UniProtKB.
DR   GO; GO:0016607; C:nuclear speck; IEA:UniProtKB-SubCell.
DR   GO; GO:0005654; C:nucleoplasm; IDA:HPA.
DR   GO; GO:0005634; C:nucleus; IDA:UniProtKB.
DR   GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW.
DR   GO; GO:0042802; F:identical protein binding; IPI:IntAct.
DR   GO; GO:0106310; F:protein serine kinase activity; IEA:RHEA.
DR   GO; GO:0004674; F:protein serine/threonine kinase activity; ISS:UniProtKB.
DR   GO; GO:0004712; F:protein serine/threonine/tyrosine kinase activity; IEA:UniProtKB-EC.
DR   GO; GO:0004713; F:protein tyrosine kinase activity; IBA:GO_Central.
DR   GO; GO:0003723; F:RNA binding; HDA:UniProtKB.
DR   GO; GO:0018108; P:peptidyl-tyrosine phosphorylation; IBA:GO_Central.
DR   GO; GO:0046777; P:protein autophosphorylation; IEA:Ensembl.
DR   GO; GO:0006468; P:protein phosphorylation; IDA:UniProtKB.
DR   GO; GO:0043484; P:regulation of RNA splicing; IDA:UniProtKB.
DR   InterPro; IPR011009; Kinase-like_dom_sf.
DR   InterPro; IPR000719; Prot_kinase_dom.
DR   InterPro; IPR017441; Protein_kinase_ATP_BS.
DR   InterPro; IPR008271; Ser/Thr_kinase_AS.
DR   Pfam; PF00069; Pkinase; 1.
DR   SMART; SM00220; S_TKc; 1.
DR   SUPFAM; SSF56112; SSF56112; 1.
DR   PROSITE; PS00107; PROTEIN_KINASE_ATP; 1.
DR   PROSITE; PS50011; PROTEIN_KINASE_DOM; 1.
DR   PROSITE; PS00108; PROTEIN_KINASE_ST; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Alternative splicing; ATP-binding; Cytoplasm;
KW   Cytoplasmic vesicle; Kinase; Nucleotide-binding; Nucleus; Phosphoprotein;
KW   Reference proteome; Serine/threonine-protein kinase; Transferase;
KW   Tyrosine-protein kinase.
FT   CHAIN           1..638
FT                   /note="Dual specificity protein kinase CLK3"
FT                   /id="PRO_0000085870"
FT   DOMAIN          304..620
FT                   /note="Protein kinase"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00159"
FT   REGION          1..134
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          177..286
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        177..226
FT                   /note="Basic and acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        237..266
FT                   /note="Basic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   ACT_SITE        431
FT                   /note="Proton acceptor"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00159,
FT                   ECO:0000255|PROSITE-ProRule:PRU10027"
FT   BINDING         310..318
FT                   /ligand="ATP"
FT                   /ligand_id="ChEBI:CHEBI:30616"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00159"
FT   BINDING         334
FT                   /ligand="ATP"
FT                   /ligand_id="ChEBI:CHEBI:30616"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00159"
FT   MOD_RES         155
FT                   /note="Phosphotyrosine"
FT                   /evidence="ECO:0007744|PubMed:18669648"
FT   MOD_RES         157
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:18669648,
FT                   ECO:0007744|PubMed:19690332, ECO:0007744|PubMed:23186163,
FT                   ECO:0007744|PubMed:24275569"
FT   MOD_RES         197
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:23186163"
FT   MOD_RES         199
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:23186163"
FT   MOD_RES         215
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:20068231"
FT   MOD_RES         224
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:18669648,
FT                   ECO:0007744|PubMed:20068231"
FT   MOD_RES         226
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:18669648,
FT                   ECO:0007744|PubMed:20068231"
FT   MOD_RES         283
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:18691976,
FT                   ECO:0007744|PubMed:23186163"
FT   VAR_SEQ         1..148
FT                   /note="Missing (in isoform 1, isoform 2 and isoform 3)"
FT                   /evidence="ECO:0000303|PubMed:15489334,
FT                   ECO:0000303|PubMed:7990150, ECO:0000303|Ref.2"
FT                   /id="VSP_026138"
FT   VAR_SEQ         272..300
FT                   /note="RSQQSSKRSSRSVEDDKEGHLVCRIGDWL -> MRLWGTWVKAPLARWWSAW
FT                   TMPEGSLRLP (in isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:7990150"
FT                   /id="VSP_004858"
FT   VAR_SEQ         301..638
FT                   /note="Missing (in isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:7990150"
FT                   /id="VSP_004859"
FT   VAR_SEQ         306..328
FT                   /note="Missing (in isoform 3)"
FT                   /evidence="ECO:0000303|PubMed:15489334"
FT                   /id="VSP_004860"
FT   VARIANT         486
FT                   /note="R -> C (in dbSNP:rs975796055)"
FT                   /evidence="ECO:0000269|PubMed:17344846"
FT                   /id="VAR_040413"
FT   VARIANT         607
FT                   /note="Q -> R (in dbSNP:rs910378995)"
FT                   /evidence="ECO:0000269|PubMed:17344846"
FT                   /id="VAR_045579"
FT   VARIANT         628
FT                   /note="R -> W (in dbSNP:rs920443187)"
FT                   /evidence="ECO:0000269|PubMed:17344846"
FT                   /id="VAR_045580"
FT   CONFLICT        280..281
FT                   /note="SS -> TG (in Ref. 1; AAA61484)"
FT                   /evidence="ECO:0000305"
FT   HELIX           277..282
FT                   /evidence="ECO:0007829|PDB:6FYR"
FT   STRAND          288..290
FT                   /evidence="ECO:0007829|PDB:6RCT"
FT   TURN            301..303
FT                   /evidence="ECO:0007829|PDB:6FYR"
FT   STRAND          304..313
FT                   /evidence="ECO:0007829|PDB:6FYR"
FT   STRAND          316..323
FT                   /evidence="ECO:0007829|PDB:6FYR"
FT   HELIX           324..326
FT                   /evidence="ECO:0007829|PDB:6FYR"
FT   STRAND          330..336
FT                   /evidence="ECO:0007829|PDB:6FYR"
FT   HELIX           340..359
FT                   /evidence="ECO:0007829|PDB:6FYR"
FT   STRAND          360..363
FT                   /evidence="ECO:0007829|PDB:6KHF"
FT   STRAND          370..376
FT                   /evidence="ECO:0007829|PDB:6FYR"
FT   STRAND          379..385
FT                   /evidence="ECO:0007829|PDB:6FYR"
FT   HELIX           391..397
FT                   /evidence="ECO:0007829|PDB:6FYR"
FT   TURN            398..400
FT                   /evidence="ECO:0007829|PDB:6FYR"
FT   HELIX           405..424
FT                   /evidence="ECO:0007829|PDB:6FYR"
FT   HELIX           434..436
FT                   /evidence="ECO:0007829|PDB:6FYR"
FT   STRAND          437..440
FT                   /evidence="ECO:0007829|PDB:6FYR"
FT   STRAND          444..448
FT                   /evidence="ECO:0007829|PDB:6FYR"
FT   TURN            450..453
FT                   /evidence="ECO:0007829|PDB:6Z55"
FT   STRAND          456..460
FT                   /evidence="ECO:0007829|PDB:6FYR"
FT   STRAND          464..466
FT                   /evidence="ECO:0007829|PDB:6FYR"
FT   HELIX           469..471
FT                   /evidence="ECO:0007829|PDB:2EXE"
FT   STRAND          473..477
FT                   /evidence="ECO:0007829|PDB:6KHF"
FT   HELIX           486..488
FT                   /evidence="ECO:0007829|PDB:6FYR"
FT   HELIX           491..494
FT                   /evidence="ECO:0007829|PDB:6FYR"
FT   HELIX           502..517
FT                   /evidence="ECO:0007829|PDB:6FYR"
FT   HELIX           527..538
FT                   /evidence="ECO:0007829|PDB:6FYR"
FT   HELIX           543..548
FT                   /evidence="ECO:0007829|PDB:6FYR"
FT   HELIX           552..554
FT                   /evidence="ECO:0007829|PDB:6FYR"
FT   STRAND          564..566
FT                   /evidence="ECO:0007829|PDB:6RCT"
FT   HELIX           567..575
FT                   /evidence="ECO:0007829|PDB:6FYR"
FT   HELIX           579..582
FT                   /evidence="ECO:0007829|PDB:6FYR"
FT   HELIX           588..600
FT                   /evidence="ECO:0007829|PDB:6FYR"
FT   TURN            605..607
FT                   /evidence="ECO:0007829|PDB:6FYR"
FT   HELIX           611..614
FT                   /evidence="ECO:0007829|PDB:6FYR"
FT   HELIX           618..622
FT                   /evidence="ECO:0007829|PDB:6FYR"
FT   TURN            625..628
FT                   /evidence="ECO:0007829|PDB:6FYR"
SQ   SEQUENCE   638 AA;  73515 MW;  D3B60A9DB4ECEC94 CRC64;
     MPVLSARRRE LADHAGSGRR SGPSPTARSG PHLSALRAQP ARAAHLSGRG TYVRRDTAGG
     GPGQARPLGP PGTSLLGRGA RRSGEGWCPG AFESGARAAR PPSRVEPRLA TAASREGAGL
     PRAEVAAGSG RGARSGEWGL AAAGAWETMH HCKRYRSPEP DPYLSYRWKR RRSYSREHEG
     RLRYPSRREP PPRRSRSRSH DRLPYQRRYR ERRDSDTYRC EERSPSFGED YYGPSRSRHR
     RRSRERGPYR TRKHAHHCHK RRTRSCSSAS SRSQQSSKRS SRSVEDDKEG HLVCRIGDWL
     QERYEIVGNL GEGTFGKVVE CLDHARGKSQ VALKIIRNVG KYREAARLEI NVLKKIKEKD
     KENKFLCVLM SDWFNFHGHM CIAFELLGKN TFEFLKENNF QPYPLPHVRH MAYQLCHALR
     FLHENQLTHT DLKPENILFV NSEFETLYNE HKSCEEKSVK NTSIRVADFG SATFDHEHHT
     TIVATRHYRP PEVILELGWA QPCDVWSIGC ILFEYYRGFT LFQTHENREH LVMMEKILGP
     IPSHMIHRTR KQKYFYKGGL VWDENSSDGR YVKENCKPLK SYMLQDSLEH VQLFDLMRRM
     LEFDPAQRIT LAEALLHPFF AGLTPEERSF HTSRNPSR
//
